Cydan

About:

Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.

Website: http://www.cydanco.com

Twitter/X: cydanco

Top Investors: Alexandria Real Estate Equities, New Enterprise Associates, Alexandria Venture Investments, Longitude Capital, Pfizer Venture Investments

Description:

Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.